Thrombocyte aggregation inhibiting composition and methods
    1.
    发明授权
    Thrombocyte aggregation inhibiting composition and methods 失效
    血小板聚集抑制组成及方法

    公开(公告)号:US4279914A

    公开(公告)日:1981-07-21

    申请号:US64540

    申请日:1979-08-07

    摘要: Platelet aggregation inhibiting compositions containing as active agent at least one compound selected from the group consisting of tetrahydroxyaporphine, glaucine containing 50 to 100% l-glaucine, and the physiologically acceptable salts and N-alkyl ammonium salts thereof are disclosed, as is a method for inhibiting platelet aggregation by administration of effective dosages of such compounds admixed with suitable carriers.

    摘要翻译: 含有作为活性剂的至少一种化合物的血小板聚集抑制组合物,其含有选自四羟基吗啡,含有50〜100%的1-亮氨酸的亮氨酸及其生理上可接受的盐和N-烷基铵盐中的至少一种化合物, 通过施用与合适的载体混合的这种化合物的有效剂量来抑制血小板聚集。

    Preparation of thioethers
    4.
    发明授权
    Preparation of thioethers 失效
    硫醚的制备

    公开(公告)号:US4267375A

    公开(公告)日:1981-05-12

    申请号:US945273

    申请日:1978-09-25

    IPC分类号: C07C149/30

    CPC分类号: C07C319/14

    摘要: Thioethers may be prepared by reacting a thiol, such as thiophenol, with an alcohol (having electron donor groups in the alpha or beta position to its hydroxyl group) such as phenyl-1-hydroxy-phenethylsulfide. Reaction is carried out in the presence of a Lewis Acid metal halide, typically zinc chloride.

    摘要翻译: 硫醚可以通过硫醇如苯硫酚与醇(在α或β位具有电子供体基团的羟基)如苯基-1-羟基 - 苯乙基硫醚来制备。 反应在路易斯酸金属卤化物(通常为氯化锌)存在下进行。